MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/cid/ciz474

Медицинская библиотека · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019

Pediatric Bacterial Meningitis Surveillance in Nigeria From 2010 to 2016, Prior to and During the Phased Introduction of the 10-Valent Pneumococcal Conjugate Vaccine.

Tagbo Beckie N, Bancroft Rowan E, Fajolu Iretiola, Abdulkadir Mohammed B, Bashir Muhammad F, Okunola Olusola P, Isiaka Ayodeji H, Lawal Namadi M, Edelu Benedict O, Onyejiaka Ngozi, Ihuoma Chinonyerem J, Ndu Florence, Ozumba Uchenna C, Udeinya Frances, Ogunsola Folasade, Saka Aishat O, Fadeyi Abayomi, Aderibigbe Sunday A, Abdulraheem Jimoh, Yusuf Adamu G, Sylvanus Ndow Peter, Ogbogu Philomena, Kanu Chinomnso, Emina Velly, Makinwa Olajumoke J, Gehre Florian, Yusuf Kabir, Braka Fiona, Mwenda Jason M, Ticha Johnson M, Nwodo Dorothy, Worwui Archibald, Biey Joseph N, Kwambana-Adams Brenda A, Antonio Martin

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Historically, Nigeria has experienced large bacterial meningitis outbreaks with high mortality in children. Streptococcus pneumoniae (pneumococcus), Neisseria meningitidis (meningococcus), and Haemophilus influenzae are major causes of this invasive disease. In collaboration with the World Health Organization, we conducted longitudinal surveillance in sentinel hospitals within Nigeria to establish the burden of pediatric bacterial meningitis (PBM).

METHODS

From 2010 to 2016, cerebrospinal fluid was collected from children <5 years of age, admitted to 5 sentinel hospitals in 5 Nigerian states. Microbiological and latex agglutination techniques were performed to detect the presence of pneumococcus, meningococcus, and H. influenzae. Species-specific polymerase chain reaction and serotyping/grouping were conducted to determine specific causative agents of PBM.

RESULTS

A total of 5134 children with suspected meningitis were enrolled at the participating hospitals; of these 153 (2.9%) were confirmed PBM cases. The mortality rate for those infected was 15.0% (23/153). The dominant pathogen was pneumococcus (46.4%: 71/153) followed by meningococcus (34.6%: 53/153) and H. influenzae (19.0%: 29/153). Nearly half the pneumococcal meningitis cases successfully serotyped (46.4%: 13/28) were caused by serotypes that are included in the 10-valent pneumococcal conjugate vaccine. The most prevalent meningococcal and H. influenzae strains were serogroup W and serotype b, respectively.

CONCLUSIONS

Vaccine-type bacterial meningitis continues to be common among children <5 years in Nigeria. Challenges with vaccine introduction and coverage may explain some of these finding. Continued surveillance is needed to determine the distribution of serotypes/groups of meningeal pathogens across Nigeria and help inform and sustain vaccination policies in the country.

Для цитирования: Tagbo Beckie N, Bancroft Rowan E, Fajolu Iretiola, Abdulkadir Mohammed B, Bashir Muhammad F, Okunola Olusola P, Isiaka Ayodeji H, Lawal Namadi M, Edelu Benedict O, Onyejiaka Ngozi, Ihuoma Chinonyerem J, Ndu Florence, Ozumba Uchenna C, Udeinya Frances, Ogunsola Folasade, Saka Aishat O, Fadeyi Abayomi, Aderibigbe Sunday A, Abdulraheem Jimoh, Yusuf Adamu G, Sylvanus Ndow Peter, Ogbogu Philomena, Kanu Chinomnso, Emina Velly, Makinwa Olajumoke J, Gehre Florian, Yusuf Kabir, Braka Fiona, Mwenda Jason M, Ticha Johnson M, Nwodo Dorothy, Worwui Archibald, Biey Joseph N, Kwambana-Adams Brenda A, Antonio Martin. Pediatric Bacterial Meningitis Surveillance in Nigeria From 2010 to 2016, Prior to and During the Phased Introduction of the 10-Valent Pneumococcal Conjugate Vaccine.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2019. DOI: 10.1093/cid/ciz474.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.